^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Acute Lymphocytic Leukemia |
| Drug: | mercaptopurine (DNA synthesis inhibitor, PRPP amidotransferase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/29/2020
Excerpt:
Mercaptopurine Tablets is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
